Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Juvaris BioTherapeutics was created in 2002 to develop an immunotherapeutic product platform for the treatment of infectious diseases and cancer using lipid-DNA complexes. Cationic lipids are formulated with non-coding DNA (plasmid) to create JuvImmuneTM, a single lipid-DNA complex, which as an immunostimulation product will have utility in a number of non-antigen immunotherapeutic applications. The DNA in these complexes does not code for protein, but rather, through a combined synergistic effect with lipids, strongly stimulates immune responses. The JuvImmuneTM product has been shown to be at least 50-times more potent at triggering innate immune activation and interferon release than current immune stimulants. Juvaris was recently issued Patent ( www.juvaris.com )
Juvaris BioTherapeutics , Inc.
6200 Stoneridge Mall Road 3Rd Floor
Pleasanton, California 94588
USA
Tel: (925) 399-6200
Fax: (925) 399-6100